313 related articles for article (PubMed ID: 38732254)
41. A comprehensive review on the dynamic role of toll-like receptors (TLRs) in frontier aquaculture research and as a promising avenue for fish disease management.
Mahapatra S; Ganguly B; Pani S; Saha A; Samanta M
Int J Biol Macromol; 2023 Dec; 253(Pt 1):126541. PubMed ID: 37648127
[TBL] [Abstract][Full Text] [Related]
42. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
43. TLR signaling by tumor and immune cells: a double-edged sword.
Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
[TBL] [Abstract][Full Text] [Related]
44. Targeting Toll-like receptors in autoimmunity.
Midwood KS; Piccinini AM; Sacre S
Curr Drug Targets; 2009 Nov; 10(11):1139-55. PubMed ID: 19715534
[TBL] [Abstract][Full Text] [Related]
45. [Progress of research on TLRs-mediated signaling pathway].
Chang XT; Nian XF; Wang ZH
Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):340-6. PubMed ID: 22242400
[TBL] [Abstract][Full Text] [Related]
46. Toll-Like Receptor Signaling and Its Inducible Proteins.
Satoh T; Akira S
Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28084212
[TBL] [Abstract][Full Text] [Related]
47. Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy.
Noh JY; Yoon SR; Kim TD; Choi I; Jung H
J Immunol Res; 2020; 2020():2045860. PubMed ID: 32377528
[TBL] [Abstract][Full Text] [Related]
48. The role of Toll-like receptors in the pathogenesis of renal disease.
Czyzyk J
Semin Nephrol; 2006 Mar; 26(2):167-72. PubMed ID: 16530608
[TBL] [Abstract][Full Text] [Related]
49. Toll-like Receptors and the Control of Immunity.
Fitzgerald KA; Kagan JC
Cell; 2020 Mar; 180(6):1044-1066. PubMed ID: 32164908
[TBL] [Abstract][Full Text] [Related]
50. Toll-like receptors.
Takeda K; Akira S
Curr Protoc Immunol; 2015 Apr; 109():14.12.1-14.12.10. PubMed ID: 25845562
[TBL] [Abstract][Full Text] [Related]
51. Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals.
Vidya MK; Kumar VG; Sejian V; Bagath M; Krishnan G; Bhatta R
Int Rev Immunol; 2018 Jan; 37(1):20-36. PubMed ID: 29028369
[TBL] [Abstract][Full Text] [Related]
52. The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases.
Ciaston I; Dobosz E; Potempa J; Koziel J
Mol Aspects Med; 2022 Dec; 88():101143. PubMed ID: 36152458
[TBL] [Abstract][Full Text] [Related]
53. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
[TBL] [Abstract][Full Text] [Related]
54. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
[TBL] [Abstract][Full Text] [Related]
55. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
56. Toll-like receptors in human infectious diseases.
de la Barrera S; Alemán M; Sasiain Mdel C
Curr Pharm Des; 2006; 12(32):4173-84. PubMed ID: 17100620
[TBL] [Abstract][Full Text] [Related]
57. Differential Effects of Toll-Like Receptor Signaling on the Activation of Immune Responses in the Upper Respiratory Tract.
Xu M; Li N; Fan X; Zhou Y; Bi S; Shen A; Wang B
Microbiol Spectr; 2022 Feb; 10(1):e0114421. PubMed ID: 35196817
[TBL] [Abstract][Full Text] [Related]
58. Toll-like receptors in transplantation: sensing and reacting to injury.
Leventhal JS; Schröppel B
Kidney Int; 2012 May; 81(9):826-32. PubMed ID: 22297675
[TBL] [Abstract][Full Text] [Related]
59. Toll-like receptors in inflammation of the central nervous system.
Kong Y; Le Y
Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
[TBL] [Abstract][Full Text] [Related]
60. Toll-like receptors as targets for immune disorders.
Keogh B; Parker AE
Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
